An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 · American Journal of Respiratory and Critical Care Medicine · 6,022 citations
https://doi.org/10.1164/rccm.200604-571st
K
Kenneth N. Olivier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
274
Papers
31.0K
Citations
74
h-index
160
i10-index
Kenneth N. Olivier is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Mycobacterium research and diagnosis & Tuberculosis Research and Epidemiology & Cystic Fibrosis Research Advances. The author has an h-index of 74, co-authored 233 publications.
Papers by this author
worksTreatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline
2020 · Clinical Infectious Diseases · 739 citations
https://doi.org/10.1093/cid/ciaa1125
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
2012 · New England Journal of Medicine · 551 citations
https://doi.org/10.1056/nejmoa1201964
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
2016 · JCI Insight · 296 citations
https://doi.org/10.1172/jci.insight.88782
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement
2018 · European Respiratory Journal · 253 citations
https://doi.org/10.1183/13993003.00170-2018
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease
2016 · American Journal of Respiratory and Critical Care Medicine · 243 citations
https://doi.org/10.1164/rccm.201604-0700oc
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat